ClearPoint Neuro, Inc.
CLPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $23 | $28 | $54 |
| Short-Term Investments | $0 | $0 | $10 | $0 |
| Receivables | $5 | $4 | $3 | $2 |
| Inventory | $7 | $8 | $9 | $5 |
| Other Curr. Assets | $2 | $1 | $2 | $1 |
| Total Curr. Assets | $33 | $36 | $51 | $62 |
| Property Plant & Equip (Net) | $5 | $5 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $1 | $1 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $6 | $6 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $39 | $43 | $55 | $66 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $0 | $0 |
| Short-Term Debt | $1 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $3 | $1 | $1 |
| Other Curr. Liab. | $6 | $4 | $5 | $3 |
| Total Curr. Liab. | $10 | $7 | $7 | $5 |
| LT Debt | $3 | $14 | $11 | $12 |
| Deferred Rev, NC | $0 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $14 | $12 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $2 | $2 |
| Total Liabilities | $14 | $21 | $19 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$191 | -$172 | -$150 | -$134 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $216 | $193 | $187 | $182 |
| Total Equity | $25 | $21 | $37 | $49 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $39 | $43 | $55 | $66 |
| Net Debt | -$17 | -$9 | -$16 | -$42 |